Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 3, 2010

Premium

Norrie Russell has been appointed president of Gene Logic, an Ocimum Biosolutions company, Ocimum announced this week.

Prior to joining Gene Logic, Russell held leadership roles with NovaRx, Invitrogen, Aviva Biosciences, and Lynx Therapeutics. He also worked at AstraZeneca, where he was global head of biological science and technology.

Russell holds a PhD in physiology from Glasgow University in Scotland.


San Francisco-based molecular diagnostics startup MLC Dx recently disclosed several company executives in a filing with the US Securities and Exchange Commission.

Thomas Willis is the company's president and CEO. Prior to that, he worked at Affymetrix, following the firm’s acquisition of ParAllele BioScience, a company he co-founded and where he served as CEO and later as chief scientific officer.

Malek Faham is the firm's CSO. Previously, he was vice president of oncology technology research at Affymetrix, and before that, director of research at ParAllele, which he also co-founded.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.